Grace Boland (Dublin Fingal West, Fine Gael)
Link to this: Individually | In context

2641. To ask the Minister for Health the plans her Department has to include Amfexa (quick release Dexamfetamine) for the treatment of ADHD in the drugs payment scheme; and if she will make a statement on the matter. [47107/25]

Jennifer Carroll MacNeill (Dún Laoghaire, Fine Gael)
Link to this: Individually | In context

Under the Health (Pricing and Supply of Medical Goods) Act 2013, the HSE has statutory responsibility for decisions on the pricing and reimbursement of medicines and medical devices; therefore, the matter has been referred to the HSE for attention and direct reply to the Deputy.

Grace Boland (Dublin Fingal West, Fine Gael)
Link to this: Individually | In context

2642. To ask the Minister for Health whether the demand for HRT medication has increased since the launch of the free HRT scheme in June 2025; and if she will make a statement on the matter. [47108/25]

Jennifer Carroll MacNeill (Dún Laoghaire, Fine Gael)
Link to this: Individually | In context

The Hormone Replacement Therapy (HRT) arrangement commenced on 1st June 2025. There is only one month of claiming data available under that arrangement which is insufficient to make definitive claims about the impact on trends in the use of HRT.

In addition, the Health Service Executive (HSE) does not have data on the private access and use of HRT prior to the commencement of the arrangement, which would further limit the ability of the HSE to make definite comparisons in HRT use between before and after the launch of the HRT arrangement.